Ovatools could be used to select high-risk women for expedited investigation, such as ≥3% risk to trigger urgent cancer referral in CA125-tested women in line with the 3% NICE threshold for urgent referral of symptomatic patients for other cancers [17]. Here, MUC16 is linked to cancer.